ArticleJournal of managed care & specialty pharmacy2026
Prevalence of renal and bone risk factors and nucleos(t)ide analogue treatment among patients with chronic hepatitis B in the United States.
Alice E Stead et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.